National Guideline Clearinghouse | Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis.
July 8, 2013
Guideline Title
Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis.
Bibliographic Source(s)
| National Institute for Health and Clinical Excellence (NICE). Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis. London (UK): National Institute for Health and Clinical Excellence (NICE); 2013 Mar. 62 p. (Technology appraisal guidance; no. 276). |
Guideline Status
This is the current release of the guideline.
No hay comentarios:
Publicar un comentario